Bioequivalence and Bioavailability

Bioavailability:  The rate and extent to which an active ingredient or active component of a drug product is absorbed and made available at the site of action is known as bioavailability. The area under the blood or plasma concentration-time curve and the highest concentration are typically used to determine the extent and pace of drug absorption, respectively.

Bioequivalence: Two drug products or two drug formulations are said to be bioequivalent or therapeutically equivalent when they have the same therapeutic impact. This indicates that there is no discernible difference in their rates and levels of absorption at the site of action.

    Related Conference of Bioequivalence and Bioavailability

    July 25-26, 2024

    4th International Conference on Biomedicine & Pharmacotherapy

    Prague, Czech Republic

    Bioequivalence and Bioavailability Conference Speakers